drugset / Trial / NCT01577316
Evaluate the Immunogenicity and Safety of the 2011-2012 Vaccine Against Seasonal Influenza on Pregnant Women
Phase 2/3
Unknown
240 enrolled
National Institute of Public Health, Mexico
Laboratorios de Biologicos y Reactivos de México, S.A. de C.V. · collab
Non-randomizedParallel-groupOpen-labelPrevention
Summary
The hypothesis proposed in this study is that the 2011-2012 Seasonal Influenza Vaccine (including H3N2 and H1N1 subtypes of serotype A strain over the serotype B) administered to 15ug (without adjuvant) via intramuscular in pregnant women will be safe and immunogenic.
Timeline
- Start
- 2012-04
- Primary completion
- 2012-12
- Completion
- 2013-12
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | 2011-2012 Seasonal Trivalent Inactivated Influenza Vaccine | Vaccine | 15 ug | Intramuscular |